TC Biopharm Ownership 2024 | Who Owns TC Biopharm Now?
Institutional Ownership
0.22%
Insider Ownership
0.01%
Retail Ownership
99.78%
Institutional Holders
5.00
TC Biopharm Institutional Shareholders
Institutional Shareholders by % of Total Shares
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
ARMISTICE CAPITAL, LLC | 21.87% | 0.00% | 120,684 | 37,972 | 45.91% | 193,094,000 | Mar 31, 2023 |
WELLS FARGO & COMPANY/MN | 1.27% | - | 7,000 | 7,000 | 100.00% | 11,200,000 | Mar 31, 2023 |
STEWARD FINANCIAL GROUP LLC | 0.36% | 0.00% | 2,000 | 2,000 | 100.00% | 3,000 | Mar 31, 2023 |
MORGAN STANLEY | 0.00% | - | 20 | 20 | 100.00% | 32,000 | Mar 31, 2023 |
UBS GROUP AG | - | - | - | -1,392 | -100.00% | - | Mar 31, 2023 |
Institutional Shareholders by % of Total Assets
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
ARMISTICE CAPITAL, LLC | 21.87% | 0.00% | 120,684 | 37,972 | 45.91% | 193,094,000 | Mar 31, 2023 |
STEWARD FINANCIAL GROUP LLC | 0.36% | 0.00% | 2,000 | 2,000 | 100.00% | 3,000 | Mar 31, 2023 |
WELLS FARGO & COMPANY/MN | 1.27% | - | 7,000 | 7,000 | 100.00% | 11,200,000 | Mar 31, 2023 |
MORGAN STANLEY | 0.00% | - | 20 | 20 | 100.00% | 32,000 | Mar 31, 2023 |
UBS GROUP AG | - | - | - | -1,392 | -100.00% | - | Mar 31, 2023 |
Institutional Buyers
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
ARMISTICE CAPITAL, LLC | 21.87% | 0.00% | 120,684 | 37,972 | 45.91% | 193,094,000 | Mar 31, 2023 |
WELLS FARGO & COMPANY/MN | 1.27% | - | 7,000 | 7,000 | 100.00% | 11,200,000 | Mar 31, 2023 |
STEWARD FINANCIAL GROUP LLC | 0.36% | 0.00% | 2,000 | 2,000 | 100.00% | 3,000 | Mar 31, 2023 |
MORGAN STANLEY | 0.00% | - | 20 | 20 | 100.00% | 32,000 | Mar 31, 2023 |
UBS GROUP AG | - | - | - | -1,392 | -100.00% | - | Mar 31, 2023 |
Institutional Sellers
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
UBS GROUP AG | - | - | - | -1,392 | -100.00% | - | Mar 31, 2023 |
MORGAN STANLEY | 0.00% | - | 20 | 20 | 100.00% | 32,000 | Mar 31, 2023 |
STEWARD FINANCIAL GROUP LLC | 0.36% | 0.00% | 2,000 | 2,000 | 100.00% | 3,000 | Mar 31, 2023 |
WELLS FARGO & COMPANY/MN | 1.27% | - | 7,000 | 7,000 | 100.00% | 11,200,000 | Mar 31, 2023 |
ARMISTICE CAPITAL, LLC | 21.87% | 0.00% | 120,684 | 37,972 | 45.91% | 193,094,000 | Mar 31, 2023 |
Institutional New positions
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
WELLS FARGO & COMPANY/MN | 1.27% | - | 7,000 | 7,000 | 100.00% | 11,200,000 | Mar 31, 2023 |
STEWARD FINANCIAL GROUP LLC | 0.36% | 0.00% | 2,000 | 2,000 | 100.00% | 3,000 | Mar 31, 2023 |
MORGAN STANLEY | 0.00% | - | 20 | 20 | 100.00% | 32,000 | Mar 31, 2023 |
Institutional Sold Out
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
UBS GROUP AG | - | - | - | -1,392 | -100.00% | - | Mar 31, 2023 |
TC Biopharm Mutual Fund Holders
Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
---|---|---|---|---|---|
TRUST FOR PROFESSIONAL MANAGERS | 0.00% | 19,068 | - | - | Feb 29, 2024 |
TC Biopharm Institutional Ownership Trends
Institutional Holdings Trend
Date | Holdings | Change % |
---|---|---|
30 Sep, 22 | 5 | - |
30 Jun, 22 | 5 | -37.50% |
31 Mar, 22 | 8 | - |
Shares Outstanding Trend
Date | Shares Outstanding | Change % |
---|---|---|
30 Sep, 22 | 507,063 | 12.34% |
30 Jun, 22 | 451,364 | 61.74% |
31 Mar, 22 | 279,073 | - |
Institutional Ownership Trend
Date | Ownership % | Change % |
---|---|---|
30 Sep, 22 | 0.22% | 583.58% |
30 Jun, 22 | 0.19% | 1359.16% |
31 Mar, 22 | 0.12% | - |
Institutional Increased Positions Trend
Date | Increased Positions | Change % |
---|---|---|
30 Sep, 22 | 3 | -40.00% |
30 Jun, 22 | 5 | -37.50% |
31 Mar, 22 | 8 | - |
Institutional Reduced Positions Trend
Date | Reduced Positions | Change % |
---|---|---|
30 Sep, 22 | 1 | - |
30 Jun, 22 | - | - |
31 Mar, 22 | - | - |
All Institutional Ownership Trend Data
Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
---|---|---|---|---|---|---|---|---|---|---|
30 Sep, 22 | 5 | - | 507,063 | 12.34% | 0.22% | 583.58% | 3 | -40.00% | 1 | - |
30 Jun, 22 | 5 | -37.50% | 451,364 | 61.74% | 0.19% | 1359.16% | 5 | -37.50% | - | - |
31 Mar, 22 | 8 | - | 279,073 | - | 0.12% | - | 8 | - | - | - |
TC Biopharm Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
Insider Sells
All Insider Owners Trades
TC Biopharm Insider Ownership Trends
All Insider Trades Trend
Date | Buy | Sell | Buy/Sell Ratio |
---|---|---|---|
Q4 2022 | 11 | - | - |
Q2 2022 | 1 | 1 | 100.00% |
Q1 2022 | - | 2 | - |
Open Market Insider Trades Trend
Date | Buy | Sell | Buy/Sell Ratio |
---|---|---|---|
Q4 2022 | 11 | - | - |
Q2 2022 | 1 | - | - |
Q1 2022 | - | - | - |
TC Biopharm Peer Ownership
Ticker | Company |
---|---|
ZVSA | ZyVersa Therapeutics, Inc. |
BDRX | Biodexa Pharmaceuticals Plc |
VIRI | Virios Therapeutics, Inc. |
ICU | SeaStar Medical Holding Corporation |
BWV | Onconetix, Inc. |
PXMD | PaxMedica, Inc. Common Stock |
PHIO | Phio Pharmaceuticals Corp. |
REVB | Revelation Biosciences, Inc. |
QNRX | Quoin Pharmaceuticals, Ltd. |
RNAZ | TransCode Therapeutics, Inc. |
HILS | Tharimmune, Inc. |
VRAX | Virax Biolabs Group Limited |
IMMX | Immix Biopharma, Inc. |
ALLR | Allarity Therapeutics, Inc. |
SONN | Sonnet BioTherapeutics Holdings, Inc. |
UNCY | Unicycive Therapeutics, Inc. |
ZURA | Zura Bio Limited |
PALI | Palisade Bio, Inc. |
TCBP Ownership FAQ
Who Owns TC Biopharm?
TC Biopharm is owned by institutional shareholders (0.22%), insiders (0.01%), and public (99.78%). The largest institutional shareholder of TC Biopharm is ARMISTICE CAPITAL, LLC (21.87% of total shares) and the top mutual fund owner is TRUST FOR PROFESSIONAL MANAGERS (0.00% of total shares).
Who are the major institutional shareholders of TC Biopharm?
TC Biopharm's major institutional shareholders are ARMISTICE CAPITAL, LLC, WELLS FARGO & COMPANY/MN, STEWARD FINANCIAL GROUP LLC, MORGAN STANLEY, and UBS GROUP AG. The top five shareholders own together 23.50% of the company's share outstanding.
How many TC Biopharm shareholders are there?
As of Sep 2022, there are 5 institutional shareholders of TC Biopharm.
What percentage of TC Biopharm is owned by ARMISTICE CAPITAL, LLC?
ARMISTICE CAPITAL, LLC owns 120.68K shares of TC Biopharm, representing 21.87% of the company's total shares outstanding, valued at $193.09M (as of Mar 2023).
What percentage of TC Biopharm is owned by WELLS FARGO & COMPANY/MN?
As of Mar 2023, WELLS FARGO & COMPANY/MN holds 7K shares of TC Biopharm (TCBP), compromising 1.27% of the company, valued at $11.2M.
What percentage of TC Biopharm is owned by STEWARD FINANCIAL GROUP LLC?
STEWARD FINANCIAL GROUP LLC is the third largest holder of TC Biopharm. The company owns 2K of the company's shares outstanding (worth $3K).